Threw this one in the hat yesterday, figured I'd give you a bit more info,FWIW..(Bio-Technolgy General) is an interesting little bio-tech,PE's a little lofty(22-23),but then it is a growth bio-tech. Posted .10 vs .09 for the 3rd quarter.Zacks and First call have raised estimates(they exceeded estimates by .02 for Q3). Is listed (Sept.28/98)as one of Fortune mag's 100 fastest growing companies(based on earnings per share,over a 3 year period).Has a strong buy rating from one analyst. Posted .31 last year and should well exceed that this year (at .26 already)
They just hired a new VP ,"Lawrence B. Brown has 15 years of experience in corporate finance, business law and business development. Prior to..joining BTG, Mr. Brown was Director, Business Development at Centocor, Inc.,where he also previously served as
Corporate Counsel."--IMO, a very good move by the company.
quote.yahoo.com
Might be worth a look, I'm longer term on this one..DD
PS: hoping it will break 7.75-8.00 and continue to move upwards towards 9.00 (disclaimer-of course, hoping doesn't make it happen<lol>)
Analyst stated "Business Week said Bio-Tech has a deal with Sumitomo to sell Bio-Tropin in Japan, which could push the company's
growth hormone sales in that country to $30 million annually by 2000."
.................
They had some bad news in Jan. from the FDA,that combined with the market slide hit this company hard,although it has bounced from around 4.5 to 7.5 since its lows... |
